NCT00257049View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Levofloxacin Compared With Ceftriaxone Sodium or Cefuroxime Axetil in the Treatment of Adults With Pneumonia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

604

Participants

Timeline

Start Date

January 31, 1984

Study Completion Date

January 31, 1995

Conditions
Pneumonia
Interventions
DRUG

levofloxacin

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

NCT00257049 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Ceftriaxone Sodium or Cefuroxime Axetil in the Treatment of Adults With Pneumonia | Biotech Hunter | Biotech Hunter